2-(4-(DiMethylaMino)phenyl)-7,8-diMethoxy-4H-chroMen-4-one HBr
![]() |
- $155 - $2000
- Product name: 2-(4-(DiMethylaMino)phenyl)-7,8-diMethoxy-4H-chroMen-4-one HBr
- CAS: 1205548-03-3
- MF: C19H19NO4
- MW: 325.36
- EINECS:
- MDL Number:MFCD19443942
- Synonyms:2-(4-(DiMethylaMino)phenyl)-7,8-diMethoxy-4H-chroMen-4-one HBr;2-(4-(Dimethylamino)phenyl)-7,8-dimethoxy-4H-chromen-4-one hydrobromide;4'-DiMethylaMino 7,8-Dihydroxyflavone DiMethyl Ether;4H-1-Benzopyran-4-one, 2-[4-(dimethylamino)phenyl]-7,8-dimethoxy-
3 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 25mg
- 250mg
- ManufacturerMedical Isotopes, Inc.
- Product number40008
- Product description4??-Dimethylamino7,8-DihydroxyflavoneDimethylEther
- Packaging250mg
- Price$2000
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD461125
- Product description4''-Dimethylamino7,8-DihydroxyflavoneDimethylEther
- Packaging25mg
- Price$155
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD461125
- Product description4''-Dimethylamino7,8-DihydroxyflavoneDimethylEther
- Packaging250mg
- Price$1210
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 40008 | 4??-Dimethylamino7,8-DihydroxyflavoneDimethylEther | 250mg | $2000 | 2021-12-16 | Buy |
TRC | D461125 | 4''-Dimethylamino7,8-DihydroxyflavoneDimethylEther | 25mg | $155 | 2021-12-16 | Buy |
TRC | D461125 | 4''-Dimethylamino7,8-DihydroxyflavoneDimethylEther | 250mg | $1210 | 2021-12-16 | Buy |
Properties
Melting point :198-203°C
storage temp. :Refrigerator
solubility :Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly, Heated)
form :Solid
color :Yellow to Very Dark Yellow
storage temp. :Refrigerator
solubility :Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly, Heated)
form :Solid
color :Yellow to Very Dark Yellow
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|